Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :
HRSA Sociedade de Advogados‘ dispute resolution department operates in several regulated industries, but sees its most notable matters in the pharmaceutical sector. Owing to this, the team often handles high-value disputes requiring expertise in pharmaceutical regulation, as well as annulment actions, and judicial claims involving shareholder conflicts. The team is led by Alexandre Domingues Serafim, who has notable experience in corporate disputes, Lucas Garcia de Moura Gavião, who focuses on civil, contractual, corporate and IP contentious matters, and Guilherme Gomes Pereira, noted for his proficiency in dispute resolution mandates involving succession issues, real estate and contractual law.
L’éditorial du Legal 500
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
- 'A very diverse and complete team of lawyers working in the main areas of business, contract, tax, litigation and arbitration law. A highly specialised team that deals with highly complex topics, is extremely prepared and up-to-date.'
- 'Expertise, knowledge, transparency with the client, concern for the details of the information, excellent ability to search the jurisprudence database for the prognosis of success of a claim, vast experience in the areas of activity.'
Clients clés
- Cristália Produtos Químicos Farmacêuticos
- Blau Farmacêutica S/A
Points forts
- Advised Blau Farmacêutica S.A. on cases before the STF and TCU regarding the public purchase of imunoglobulina, a medicine used to treat immunological and inflammatory disorders, conducted by the Ministry of Health.
- Advise Blau Farmacêutica S.A. on lawsuits involving the public purchase of Alfaepoetina, a medicine used to treat anemia associated with chronic renal failure, conducted by the Ministry of Health.